VOICE: An Early Feasibility Study of a Precise Robotically Implanted Brain-Computer Interface for Communication Restoration
Eligible age
22–75 yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The VOICE Study is an early feasibility study to evaluate the initial clinical safety and efficacy of the N1 and R1 Systems device design concept in providing an ability to communicate. The Neuralink N1 Implant is intended to provide the ability to communicate to individuals with severe and irreversible speech production impairment. It is indicated for adults with neurological conditions of the central speech pathways who have impaired upper limb function. The N1 Implant is a skull-mounted, wireless, rechargeable implant connected to electrode threads that are implanted in the brain by the R1 Robot, a robotic electrode thread inserter.
Sponsor: Neuralink Corp
You may qualify if…
- ✓ Adults with diagnosis of ALS, PLS, stroke, or Spinal Cord Injury who have severe speech impairment and impaired upper limb function.
- ✓ Life expectancy ≥ 12 months.
- ✓ Ability to communicate in English
- ✓ Presence of a stable caregiver
You may not qualify if…
- ✕ Moderate to high risk for serious perioperative adverse events
- ✕ Morbid obesity (Body Mass Index \> 40)
- ✕ History of poorly controlled seizures or epilepsy
- ✕ History of poorly controlled diabetes
- ✕ Requires magnetic resonance imaging (MRI) for any ongoing medical conditions
- ✕ Acquired or hereditary immunosuppression
- ✕ Psychiatric or psychological disorder
- ✕ Brain MRI demonstrating hemorrhage, tumor, distorted or adverse anatomy.
Where it's recruiting
Dallas
Source: ClinicalTrials.gov · NCT07224256 · last updated 2025-11-04